The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

Synopsis Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF .....

No Of Pages : 68
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF .....

No Of Pages : 93
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells. Global Epogen and Biosimilar market is projected to reach US$ 534.8 million in 2029, i.....

No Of Pages : 73
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. Global Herceptin (Trastuzumab) and Biosimilar market is projected to reach US$ 6303.7 million in 2029.....

No Of Pages : 86
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Ranibizumab is a medication used to manage and treat neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, myopic choroidal neovascularization, and diabetic retinopathy. Glo.....

No Of Pages : 74
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.It serves to stimulate the production .....

No Of Pages : 91
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. Avsola, Flixabi, Inf.....

No Of Pages : 69
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. Avsola, Flixabi, Inf.....

No Of Pages : 66
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's L.....

No Of Pages : 73
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

Synopsis RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's L.....

No Of Pages : 68
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00